[Some aspects of the pathogenetic therapy of edema in acute ischemia of the extremities].
D000818:Animals; D007611:Aprotinin / Q000008:administration & dosage; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use; D002802:Cholinesterases / Q000008:administration & dosage / Q000627:therapeutic use; D004155:Diphenhydramine / Q000008:administration & dosage / Q000627:therapeutic use; D004341:Drug Evaluation; D004487:Edema / Q000188:drug therapy*; D005730:Ganglionic Blockers / Q000008:administration & dosage / Q000627:therapeutic use; D007511:Ischemia / Q000188:drug therapy*; D007866:Leg; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D011812:Quinuclidines / Q000008:administration & dosage / Q000627:therapeutic use; D011817:Rabbits; D012039:Regional Blood Flow; D012702:Serotonin Antagonists; D013997:Time Factors; D014111:Tourniquets; D014289:Trimedoxime / Q000008:administration & dosage
D005730:Ganglionic Blockers; D011812:Quinuclidines; D012702:Serotonin Antagonists; D014289:Trimedoxime; D001285:Atropine; D004155:Diphenhydramine; D007611:Aprotinin; D011433:Propranolol; D002802:Cholinesterases
Nekotorye aspekty patogeneticheskoĭ terapii oteka pri ostroĭ ishemii konechnosteĭ